HealthTrust’s Mark Dumond, AVP of Technology Services, discusses the perennial culprits of year-over-year price increases of 5 to 10 percent on medical device technology, most of which lacks the evidence to substantiate the “latest and greatest” claims of manufacturers. The consequences of inaction on cardiovascular service line margins have never been greater.
What’s eating up cardiovascular service line margins: My ‘top 5’ list
